Two young siblings presented to the pediatric department with mental retardation, developmental delay, ataxia, and nystagmus since birth. What's your diagnosis after reviewing the case?
Studies suggest that magnesium, riboflavin, butterbur, coenzyme Q10, and certain nutraceutical combinations may have efficacy in preventing migraine. This slideshow reviews the evidence.
How common is psychosis in PD? Implications? Risk factors? Insights here, and measures that may help.
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
What do these images suggest is the cause of bilateral lower limb symptoms of 4 months’ duration?
Dr. Loeb summarizes a global and one-of-a-kind approach of biomarker and drug discovery using systems biology of human brain tissues.
OI may serve for research purposes as a simple and inexpensive indicator of evolving AD pathology. Details here.
New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
Too many—or too few—pounds—could be a factor in migraine pathogenesis. Details here.
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.